Testa I - Search Results

1

Targeted therapies in advanced renal cell carcinoma: the role of metastatic sites as a prognostic factor.

Grassi P, Verzoni E, Porcu L, Testa I, Iacovelli R, Torri V, Braud Fd, Procopio G. Grassi P, et al. Among authors: testa i. Future Oncol. 2014 Jun;10(8):1361-72. doi: 10.2217/fon.14.69. Future Oncol. 2014. PMID: 25052747

2

Lecture: management of chemotherapy-induced febrile neutropenia; guidelines and colony stimulating factors.

Procopio G, Niger M, Testa I. Procopio G, et al. Among authors: testa i. Neurol Sci. 2011 Nov;32 Suppl 2:S217-9. doi: 10.1007/s10072-011-0795-x. Neurol Sci. 2011. PMID: 22002072

3

Prognostic factors for survival in patients with metastatic renal cell carcinoma treated with targeted therapies.

Procopio G, Verzoni E, Iacovelli R, Biasoni D, Testa I, Porcu L, De Braud F. Procopio G, et al. Among authors: testa i. Br J Cancer. 2012 Oct 9;107(8):1227-32. doi: 10.1038/bjc.2012.327. Epub 2012 Sep 11. Br J Cancer. 2012. PMID: 22968651 Free PMC article.

4

Experience with sorafenib in the treatment of advanced renal cell carcinoma.

Procopio G, Verzoni E, Testa I, Nicolai N, Salvioni R, Debraud F. Procopio G, et al. Among authors: testa i. Ther Adv Urol. 2012 Dec;4(6):303-13. doi: 10.1177/1756287212457216. Ther Adv Urol. 2012. PMID: 23205057 Free PMC article.

5

Safety of Abiraterone Acetate in Castration-resistant Prostate Cancer Patients With Concomitant Cardiovascular Risk Factors.

Procopio G, Grassi P, Testa I, Verzoni E, Torri V, Salvioni R, Valdagni R, de Braud F. Procopio G, et al. Among authors: testa i. Am J Clin Oncol. 2015 Oct;38(5):479-82. doi: 10.1097/COC.0b013e3182a790ce. Am J Clin Oncol. 2015. PMID: 24064757 Clinical Trial.

6

Patient approach in advanced/metastatic renal cell carcinoma: focus on the elderly population and treatment-related toxicity.

Verzoni E, de Braud F, Fabiani F, Grassi P, Testa I, Procopio G. Verzoni E, et al. Among authors: testa i. Future Oncol. 2013 Nov;9(11):1599-607. doi: 10.2217/fon.13.150. Future Oncol. 2013. PMID: 24156321 Review.

7

Treatment of collecting duct carcinoma: current status and future perspectives.

Procopio G, Testa I, Iacovelli R, Grassi P, Verzoni E, Garanzini E, Colecchia M, Torelli T, De Braud F. Procopio G, et al. Among authors: testa i. Anticancer Res. 2014 Feb;34(2):1027-30. Anticancer Res. 2014. PMID: 24511050 Free article.

8

Rationale and protocol of RESORT, a randomized, open-label, multicenter phase II study to evaluate the efficacy of sorafenib in patients with advanced renal cell carcinoma after radical resection of the metastases.

Procopio G, Verzoni E, Biondani P, Grassi P, Testa I, Garanzini E, de Braud F. Procopio G, et al. Among authors: testa i. Tumori. 2014 Jan-Feb;100(1):e28-30. doi: 10.1700/1430.15834. Tumori. 2014. PMID: 24675507 Clinical Trial.

9

Everolimus in advanced solid tumors: when to start, early or late?

Pusceddu S, Tessari A, Testa I, Procopio G. Pusceddu S, et al. Among authors: testa i. Tumori. 2014 Jan-Feb;100(1):e2-3. doi: 10.1700/1430.15827. Tumori. 2014. PMID: 24675508

10

Targeted treatments in advanced renal cell carcinoma: focus on axitinib.

Verzoni E, Grassi P, Testa I, Iacovelli R, Biondani P, Garanzini E, De Braud F, Procopio G. Verzoni E, et al. Among authors: testa i. Pharmgenomics Pers Med. 2014 Mar 27;7:107-16. doi: 10.2147/PGPM.S37098. eCollection 2014. Pharmgenomics Pers Med. 2014. PMID: 24715765 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

184 results

Search Page

Filters